Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
4,882
archived clinical trials in
Obesity Weight Loss

Naltrexone/Bupropion Cardiovascular Outcomes Study
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated:  4/7/2016
Clinical Research Facility
mi
from
Boca Raton, FL
Naltrexone/Bupropion Cardiovascular Outcomes Study
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated: 4/7/2016
Clinical Research Facility
mi
from
Boca Raton, FL
Click here to add this to my saved trials
Naltrexone/Bupropion Cardiovascular Outcomes Study
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated:  4/7/2016
Clinical Research Facility
mi
from
Bradenton, FL
Naltrexone/Bupropion Cardiovascular Outcomes Study
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated: 4/7/2016
Clinical Research Facility
mi
from
Bradenton, FL
Click here to add this to my saved trials
Naltrexone/Bupropion Cardiovascular Outcomes Study
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated:  4/7/2016
Clinical Research Facility
mi
from
Brandon, FL
Naltrexone/Bupropion Cardiovascular Outcomes Study
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated: 4/7/2016
Clinical Research Facility
mi
from
Brandon, FL
Click here to add this to my saved trials
Naltrexone/Bupropion Cardiovascular Outcomes Study
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated:  4/7/2016
Clinical Research Facility
mi
from
Brooksville, FL
Naltrexone/Bupropion Cardiovascular Outcomes Study
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated: 4/7/2016
Clinical Research Facility
mi
from
Brooksville, FL
Click here to add this to my saved trials
Naltrexone/Bupropion Cardiovascular Outcomes Study
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated:  4/7/2016
Clinical Research Facility
mi
from
Coral Springs, FL
Naltrexone/Bupropion Cardiovascular Outcomes Study
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated: 4/7/2016
Clinical Research Facility
mi
from
Coral Springs, FL
Click here to add this to my saved trials
Naltrexone/Bupropion Cardiovascular Outcomes Study
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated:  4/7/2016
Clinical Research Facility
mi
from
Cutler Bay, FL
Naltrexone/Bupropion Cardiovascular Outcomes Study
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated: 4/7/2016
Clinical Research Facility
mi
from
Cutler Bay, FL
Click here to add this to my saved trials
Naltrexone/Bupropion Cardiovascular Outcomes Study
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated:  4/7/2016
Clinical Research Facility
mi
from
Daytona Beach, FL
Naltrexone/Bupropion Cardiovascular Outcomes Study
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated: 4/7/2016
Clinical Research Facility
mi
from
Daytona Beach, FL
Click here to add this to my saved trials
Naltrexone/Bupropion Cardiovascular Outcomes Study
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated:  4/7/2016
Clinical Research Facility
mi
from
Hialeah, FL
Naltrexone/Bupropion Cardiovascular Outcomes Study
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated: 4/7/2016
Clinical Research Facility
mi
from
Hialeah, FL
Click here to add this to my saved trials
Naltrexone/Bupropion Cardiovascular Outcomes Study
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated:  4/7/2016
Clinical Research Facility
mi
from
Inverness, FL
Naltrexone/Bupropion Cardiovascular Outcomes Study
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated: 4/7/2016
Clinical Research Facility
mi
from
Inverness, FL
Click here to add this to my saved trials
Naltrexone/Bupropion Cardiovascular Outcomes Study
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated:  4/7/2016
Clinical Research Facility
mi
from
Jacksonville Beach, FL
Naltrexone/Bupropion Cardiovascular Outcomes Study
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated: 4/7/2016
Clinical Research Facility
mi
from
Jacksonville Beach, FL
Click here to add this to my saved trials
Naltrexone/Bupropion Cardiovascular Outcomes Study
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated:  4/7/2016
Clinical Research Facility
mi
from
Lake Worth, FL
Naltrexone/Bupropion Cardiovascular Outcomes Study
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated: 4/7/2016
Clinical Research Facility
mi
from
Lake Worth, FL
Click here to add this to my saved trials
Naltrexone/Bupropion Cardiovascular Outcomes Study
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated:  4/7/2016
Clinical Research Facility
mi
from
Largo, FL
Naltrexone/Bupropion Cardiovascular Outcomes Study
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated: 4/7/2016
Clinical Research Facility
mi
from
Largo, FL
Click here to add this to my saved trials
Naltrexone/Bupropion Cardiovascular Outcomes Study
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated:  4/7/2016
Clinical Research Facility
mi
from
Miami Lakes, FL
Naltrexone/Bupropion Cardiovascular Outcomes Study
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated: 4/7/2016
Clinical Research Facility
mi
from
Miami Lakes, FL
Click here to add this to my saved trials
Naltrexone/Bupropion Cardiovascular Outcomes Study
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated:  4/7/2016
Clinical Research Facility
mi
from
Orlando, FL
Naltrexone/Bupropion Cardiovascular Outcomes Study
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated: 4/7/2016
Clinical Research Facility
mi
from
Orlando, FL
Click here to add this to my saved trials
Naltrexone/Bupropion Cardiovascular Outcomes Study
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated:  4/7/2016
Clinical Research Facility
mi
from
Palm Harbor, FL
Naltrexone/Bupropion Cardiovascular Outcomes Study
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated: 4/7/2016
Clinical Research Facility
mi
from
Palm Harbor, FL
Click here to add this to my saved trials
Naltrexone/Bupropion Cardiovascular Outcomes Study
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated:  4/7/2016
Clinical Research Facility
mi
from
Pembroke Pines, FL
Naltrexone/Bupropion Cardiovascular Outcomes Study
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated: 4/7/2016
Clinical Research Facility
mi
from
Pembroke Pines, FL
Click here to add this to my saved trials
Naltrexone/Bupropion Cardiovascular Outcomes Study
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated:  4/7/2016
Clinical Research Facility
mi
from
Ponte Vedra Beach, FL
Naltrexone/Bupropion Cardiovascular Outcomes Study
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated: 4/7/2016
Clinical Research Facility
mi
from
Ponte Vedra Beach, FL
Click here to add this to my saved trials
Naltrexone/Bupropion Cardiovascular Outcomes Study
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated:  4/7/2016
Clinical Research Facility
mi
from
Sarasota, FL
Naltrexone/Bupropion Cardiovascular Outcomes Study
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated: 4/7/2016
Clinical Research Facility
mi
from
Sarasota, FL
Click here to add this to my saved trials
Naltrexone/Bupropion Cardiovascular Outcomes Study
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated:  4/7/2016
Clinical Research Facility
mi
from
Stuart, FL
Naltrexone/Bupropion Cardiovascular Outcomes Study
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated: 4/7/2016
Clinical Research Facility
mi
from
Stuart, FL
Click here to add this to my saved trials
Naltrexone/Bupropion Cardiovascular Outcomes Study
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated:  4/7/2016
Clinical Research Facility
mi
from
Atlanta, GA
Naltrexone/Bupropion Cardiovascular Outcomes Study
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated: 4/7/2016
Clinical Research Facility
mi
from
Atlanta, GA
Click here to add this to my saved trials
Naltrexone/Bupropion Cardiovascular Outcomes Study
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated:  4/7/2016
Clinical Research Facility
mi
from
Duluth, GA
Naltrexone/Bupropion Cardiovascular Outcomes Study
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated: 4/7/2016
Clinical Research Facility
mi
from
Duluth, GA
Click here to add this to my saved trials
Naltrexone/Bupropion Cardiovascular Outcomes Study
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated:  4/7/2016
Clinical Research Facility
mi
from
Savannah, GA
Naltrexone/Bupropion Cardiovascular Outcomes Study
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated: 4/7/2016
Clinical Research Facility
mi
from
Savannah, GA
Click here to add this to my saved trials
Naltrexone/Bupropion Cardiovascular Outcomes Study
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated:  4/7/2016
Clinical Research Facility
mi
from
Honolulu, HI
Naltrexone/Bupropion Cardiovascular Outcomes Study
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated: 4/7/2016
Clinical Research Facility
mi
from
Honolulu, HI
Click here to add this to my saved trials
Naltrexone/Bupropion Cardiovascular Outcomes Study
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated:  4/7/2016
Clinical Research Facility
mi
from
Pocatello, ID
Naltrexone/Bupropion Cardiovascular Outcomes Study
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated: 4/7/2016
Clinical Research Facility
mi
from
Pocatello, ID
Click here to add this to my saved trials
Naltrexone/Bupropion Cardiovascular Outcomes Study
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated:  4/7/2016
Clinical Research Facility
mi
from
Blue Island, IL
Naltrexone/Bupropion Cardiovascular Outcomes Study
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated: 4/7/2016
Clinical Research Facility
mi
from
Blue Island, IL
Click here to add this to my saved trials
Naltrexone/Bupropion Cardiovascular Outcomes Study
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated:  4/7/2016
Clinical Research Facility
mi
from
Chicago, IL
Naltrexone/Bupropion Cardiovascular Outcomes Study
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated: 4/7/2016
Clinical Research Facility
mi
from
Chicago, IL
Click here to add this to my saved trials
Naltrexone/Bupropion Cardiovascular Outcomes Study
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated:  4/7/2016
Clinical Research Facility
mi
from
Evanston, IL
Naltrexone/Bupropion Cardiovascular Outcomes Study
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated: 4/7/2016
Clinical Research Facility
mi
from
Evanston, IL
Click here to add this to my saved trials
Naltrexone/Bupropion Cardiovascular Outcomes Study
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated:  4/7/2016
Clinical Research Facility
mi
from
Gurnee, IL
Naltrexone/Bupropion Cardiovascular Outcomes Study
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated: 4/7/2016
Clinical Research Facility
mi
from
Gurnee, IL
Click here to add this to my saved trials
Naltrexone/Bupropion Cardiovascular Outcomes Study
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated:  4/7/2016
Clinical Research Facility
mi
from
Rock Island, IL
Naltrexone/Bupropion Cardiovascular Outcomes Study
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated: 4/7/2016
Clinical Research Facility
mi
from
Rock Island, IL
Click here to add this to my saved trials
Naltrexone/Bupropion Cardiovascular Outcomes Study
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated:  4/7/2016
Clinical Research Facility
mi
from
Evansville, IN
Naltrexone/Bupropion Cardiovascular Outcomes Study
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated: 4/7/2016
Clinical Research Facility
mi
from
Evansville, IN
Click here to add this to my saved trials
Naltrexone/Bupropion Cardiovascular Outcomes Study
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated:  4/7/2016
Clinical Research Facility
mi
from
Topeka, KA
Naltrexone/Bupropion Cardiovascular Outcomes Study
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated: 4/7/2016
Clinical Research Facility
mi
from
Topeka, KA
Click here to add this to my saved trials
Naltrexone/Bupropion Cardiovascular Outcomes Study
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated:  4/7/2016
Clinical Research Facility
mi
from
Louisville, KY
Naltrexone/Bupropion Cardiovascular Outcomes Study
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated: 4/7/2016
Clinical Research Facility
mi
from
Louisville, KY
Click here to add this to my saved trials
Naltrexone/Bupropion Cardiovascular Outcomes Study
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated:  4/7/2016
Clinical Research Facility
mi
from
Owensboro, KY
Naltrexone/Bupropion Cardiovascular Outcomes Study
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated: 4/7/2016
Clinical Research Facility
mi
from
Owensboro, KY
Click here to add this to my saved trials
Naltrexone/Bupropion Cardiovascular Outcomes Study
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated:  4/7/2016
Clinical Research Facility
mi
from
Baton Rouge, LA
Naltrexone/Bupropion Cardiovascular Outcomes Study
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated: 4/7/2016
Clinical Research Facility
mi
from
Baton Rouge, LA
Click here to add this to my saved trials
Naltrexone/Bupropion Cardiovascular Outcomes Study
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated:  4/7/2016
Clinical Research Facility
mi
from
Bossier City, LA
Naltrexone/Bupropion Cardiovascular Outcomes Study
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated: 4/7/2016
Clinical Research Facility
mi
from
Bossier City, LA
Click here to add this to my saved trials
Naltrexone/Bupropion Cardiovascular Outcomes Study
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated:  4/7/2016
Clinical Research Facility
mi
from
Lake Charles, LA
Naltrexone/Bupropion Cardiovascular Outcomes Study
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated: 4/7/2016
Clinical Research Facility
mi
from
Lake Charles, LA
Click here to add this to my saved trials
Naltrexone/Bupropion Cardiovascular Outcomes Study
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated:  4/7/2016
Clinical Research Facility
mi
from
Shreveport, LA
Naltrexone/Bupropion Cardiovascular Outcomes Study
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated: 4/7/2016
Clinical Research Facility
mi
from
Shreveport, LA
Click here to add this to my saved trials
Naltrexone/Bupropion Cardiovascular Outcomes Study
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated:  4/7/2016
Clinical Research Facility
mi
from
Baltimore, MD
Naltrexone/Bupropion Cardiovascular Outcomes Study
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated: 4/7/2016
Clinical Research Facility
mi
from
Baltimore, MD
Click here to add this to my saved trials
Naltrexone/Bupropion Cardiovascular Outcomes Study
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated:  4/7/2016
Clinical Research Facility
mi
from
Catonsville, MD
Naltrexone/Bupropion Cardiovascular Outcomes Study
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated: 4/7/2016
Clinical Research Facility
mi
from
Catonsville, MD
Click here to add this to my saved trials
Naltrexone/Bupropion Cardiovascular Outcomes Study
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated:  4/7/2016
Clinical Research Facility
mi
from
Bay City, MI
Naltrexone/Bupropion Cardiovascular Outcomes Study
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated: 4/7/2016
Clinical Research Facility
mi
from
Bay City, MI
Click here to add this to my saved trials
Naltrexone/Bupropion Cardiovascular Outcomes Study
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated:  4/7/2016
Clinical Research Facility
mi
from
Saginaw, MI
Naltrexone/Bupropion Cardiovascular Outcomes Study
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated: 4/7/2016
Clinical Research Facility
mi
from
Saginaw, MI
Click here to add this to my saved trials
Naltrexone/Bupropion Cardiovascular Outcomes Study
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated:  4/7/2016
Clinical Research Facility
mi
from
Port Gibson, MS
Naltrexone/Bupropion Cardiovascular Outcomes Study
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated: 4/7/2016
Clinical Research Facility
mi
from
Port Gibson, MS
Click here to add this to my saved trials
Naltrexone/Bupropion Cardiovascular Outcomes Study
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated:  4/7/2016
Clinical Research Facility
mi
from
Hazelwood, MO
Naltrexone/Bupropion Cardiovascular Outcomes Study
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated: 4/7/2016
Clinical Research Facility
mi
from
Hazelwood, MO
Click here to add this to my saved trials
Naltrexone/Bupropion Cardiovascular Outcomes Study
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated:  4/7/2016
Clinical Research Facility
mi
from
Great Falls, MT
Naltrexone/Bupropion Cardiovascular Outcomes Study
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated: 4/7/2016
Clinical Research Facility
mi
from
Great Falls, MT
Click here to add this to my saved trials
Naltrexone/Bupropion Cardiovascular Outcomes Study
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated:  4/7/2016
Clinical Research Facility
mi
from
Las Vegas, NV
Naltrexone/Bupropion Cardiovascular Outcomes Study
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated: 4/7/2016
Clinical Research Facility
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Naltrexone/Bupropion Cardiovascular Outcomes Study
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated:  4/7/2016
Clinical Research Facility
mi
from
Linden, NJ
Naltrexone/Bupropion Cardiovascular Outcomes Study
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated: 4/7/2016
Clinical Research Facility
mi
from
Linden, NJ
Click here to add this to my saved trials
Naltrexone/Bupropion Cardiovascular Outcomes Study
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated:  4/7/2016
Clinical Research Facility
mi
from
Moorestown, NJ
Naltrexone/Bupropion Cardiovascular Outcomes Study
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated: 4/7/2016
Clinical Research Facility
mi
from
Moorestown, NJ
Click here to add this to my saved trials
Naltrexone/Bupropion Cardiovascular Outcomes Study
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated:  4/7/2016
Clinical Research Facility
mi
from
Albuquerque, NM
Naltrexone/Bupropion Cardiovascular Outcomes Study
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated: 4/7/2016
Clinical Research Facility
mi
from
Albuquerque, NM
Click here to add this to my saved trials
Naltrexone/Bupropion Cardiovascular Outcomes Study
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated:  4/7/2016
Clinical Research Facility
mi
from
Endwell, NY
Naltrexone/Bupropion Cardiovascular Outcomes Study
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated: 4/7/2016
Clinical Research Facility
mi
from
Endwell, NY
Click here to add this to my saved trials
Naltrexone/Bupropion Cardiovascular Outcomes Study
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated:  4/7/2016
Clinical Research Facility
mi
from
Great Neck, NY
Naltrexone/Bupropion Cardiovascular Outcomes Study
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated: 4/7/2016
Clinical Research Facility
mi
from
Great Neck, NY
Click here to add this to my saved trials